Article 46 work-sharing

  • Afluria / Enzira (influenza virus)

    DE/W/0058/pdWS/001

    End of procedure: 20/10/2015
    Date of publication: 07/01/2016

    SE/W/013/pdWS/001
    End of procedure: 28/04/2011
    Date of publication: 06/07/2011
  • Avaxim 80U Paediatric (inactivated hepatitis A vaccine)

    HU/W/0007/pdWS/001
    End of procedure: 18/06/2013
    Date of publication: 26/09/2013

    HU/W/0007/pdWS/002
    End of procedure: 21/11/2015
    Date of publication: 30/06/2016  
  • Berinert (C1-esterase inhibitor, human)

    DE/W/0051/pdWS/002
    End of procedure: 20/07/2016
    Date of publication: 27/09/2016

    DE/W/0051/pdWS/003
    End of procedure: 02/10/2018
    Date of publication: 18/12/2018
  • Boostrix (diphtheria toxoid / tetanus toxoid / pertussis toxoid / filamentous haemagglutinin / pertactin)

    DE/W/0030/pdWS/002
    End of procedure: 04/02/2016
    Date of publication: 07/04/2016

    DE/W/0030/pdWS/005
    End of procedure: 24/02/2020
    Date of publication: 06/04/2020
  • Covaxis (Triaxis/Adacel) (diphtheria, tetanus, pertussis (acellular, component) vaccine (adsorbed, reduced antigen(s) content))

    DE/W/0034/pdWS/003
    End of procedure: 15/01/2014
    Date of publication: 06/05/2014

    DE/W/0034/pdWS/004
    End of procedure: 07/02/2016
    Date of publication: 07/04/2016

    DE/W/0034/pdWS/005
    End of procedure: 29/07/2016
    Date of publication: 27/09/2016

    DE/W/0034/pdWS/007
    End of Procedure: 17/07/2019
    Date of Publication: 25/10/2019
  • Daivobet (calcipotriol / bethamethasone)

    DK/W/0027/pdWS/001
    End of procedure: 06/02/2013
    Date of publication: 02/04/2013

    DK/W/0027/pdWS/002
    End of procedure: 26/03/2014
    Date of publication: 03/06/2014

    DK/W/0027/pdWS/003
    End of procedure: 10/08/2019
    Date of publication: 25/10/2019
  • Decapeptyl / Diphereline /Arvekap (triptorelin)

    PT/W/0003/pdWS/001
    End of procedure: 04/07/2013
    Date of publication: 16/11/2022

    PT/W/0003/pdWS/002
    End of procedure: 30/06/2023
    Date of publication: 03/04/2024
  • Diovan and related names (valsartan)

    SE/W/0026/pdWS/001
    End of procedure: 07/07/2017
    date of publication: 25/10/2017

    SE/W/0026/pdWS/002
    End of procedure: 30/10/2017
    date of publication: 20/12/2017
  • Duac Once Daily Gel (clindamycin / benzoyl peroxide)

    UK/W/0061/pdWS/001
    End of procedure: 16/09/2015
    Date of publication: 27/11/2015

    UK/W/0061/pdWS/002
    End of procedure: 10/12/2016
    Date of publication: 23/02/2017
  • Elidel (pimecrolimus)

    DK/W/007/pdWS/001
    End of procedure: 26/01/2010
    Date of publication: 27/04/2010

    DK/W/007/pdWS/002
    End of procedure: 24/08/2010
    Date of publication: 24/11/2010

    DK/W/007/pdWS/003
    End of procedure: 05/04/2011
    Date of publication: 06/06/2011
  • Famvir and associated names (famciclovir)

    DE/W/005/pdWS/001
    End of Procedure: 26/05/2010
    Date of Publication: 05/08/2010

    DE/W/005/pdWS/002
    End of Procedure: 08/06/2011
    Date of Publication: 06/07/2011
  • Fibryga (human fibrinogen)

    DE/W/0076/pdWS/001
    End of procedure: 13/06/2019
    Date of publication: 31/07/2019

    DE/W/0076/pdWS/002
    End of procedure: 22/10/2020
    Date of publication: 05/02/2021

  • Fluarix Tetra (influenza virus (inactivated, split) of each of 4 strains (two A subtypes and two B lineages))

    DE/W/0059/pdWS/002
    End of procedure: 09/12/2022
    Date of publication: 01/02/2023

    DE/W/0059/pdWS/003
    End of procedure: 31/03/2023
    Date of publication: 02/06/2023
  • Foradil Aerolizer (formoterol fumarate)

    EE/W/007/pdWS/001
    End of procedure: 17/11/2019
    Date of publication: 14/02/2020

    EE/W/006/pdWS/001
    End of procedure: 26/09/2017
    Date of publication: 09/03/2021
  • Fragmin (dalteparin sodium)

    UK/W/0112/pdWS/001

    End of procedure: 31/10/2019
    Date of publication: 06/04/2020

    SI/W/0008/pdWS/001
    End of procedure: 20/06/2023
    Date of publication: 28/07/2023
  • Genotropin and associated names (somatropin)

    DK/W/008/pdWS/001
    End of procedure: 06/10/2010
    Date of publication: 24/10/2010

    DK/W/008/pdWS/002
    End of procedure: 16/03/2011
    Date of publication: 24/11/2010
    Update: 27/04/2011

    DK/W/008/pdWS/003
    End of procedure: 27/11/2012
    Date of publication: 24/01/2013

    DK/W/008/pdWS/004
    End of procedure: 09/10/2013
    Date of publication: 02/12/2013

    DK/W/008/pdWS/005
    End of procedure: 09/08/2016
    Date of publication: 03/10/2016

    DK/W/008/pdWS/006
    End of procedure: 09/08/2016
    Date of publication: 03/10/2016

    DK/W/008/pdWS/007
    End of procedure: 07/02/2018
    Date of publication: 25/10/2018
  • Imovax Polio (poliomyelitis vaccine (inactivated))

    SK/W/0002/pdWS/001

    End of procedure: 18/04/2011
    Date of publication: 28/09/2012

    HR/W/0001/pdWS/001
    End of procedure: 06/06/2023
    Date of publication: 28/07/2023
  • Infanrix-IPV+Hib (diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed))

    DE/W/0036/pdWS/006
    End of procedure: 08/11/2016
    Date of publication: 23/02/2017

    DE/W/0036/pdWS/008
    End of procedure: 26/11/2019
    Date of publication: 14/02/2020

    DE/W/0036/pdWS/009
    End of procedure: 13/12/2023
    Date of publication: 28/02/2024
  • Lamictal (Dispers) / Lambipol (lamotrigine)

    NL/H/003/pdWS/002
    End of procedure: 26/06/2013
    Date of publication: 07/01/2016

    NL/H/003/pdWS/003
    End of procedure: 29/10/2015
    Date of publication: 26/07/2017

    NL/H/003/pdWS/004
    End of procedure: 03/05/2016
    Date of publication: 26/07/2017

    NL/H/003/pdWS/005
    End of procedure: 11/11/2016
    Date of publication: 26/07/2017
  • Menitorix (Haemophilus influenzae type b conjugate, Neisseria meningitidis capsular polysaccharide  C, tetanus toxoid conjugates)

    UK/W/028/pdWS/001
    End of Procedure: 21/03/2012
    Date of Publication: 31/10/2013

    UK/W/028/pdWS/002
    End of Procedure: 14/06/2012
    Date of Publication: 31/10/2013

    UK/W/028/pdWS/003
    End of Procedure: 20/03/2013
    Date of Publication: 31/10/2013

    UK/W/028/pdWS/004
    End of Procedure: 17/06/2013
    Date of Publication: 31/10/2013

    UK/W/028/pdWS/005
    End of Procedure:30/09/2013
    Date of Publication: 09/10/2014

    UK/W/028/pdWS/006
    End of Procedure: 12/06/2014
    Date of Publication: 04/08/2014
  • Neurontin (gabapentin)

    DE/W/041/pdWS/001
    End of procedure: 17/06/2011
    Date of publication: 08/08/2011

    DE/W/041/pdWS/002
    End of procedure: 14/12/2015
    Date of publication: 09/02/2016
  • Nexium (esomeprazole)

    SE/W/006/pdWS/001
    End of procedure: 09/12/2010
    Date of publication: 05/01/2011

    SE/W/006/pdWS/002
    End of procedure: 06/03/2017
    Date of publication: 19/06/2017
  • OctaplasLG (ABO-blood group specific human plasma proteins)

    SE/W/0028/pdWS/001
    End of procedure: 31/01/2019
    Date of publication: 11/04/2019

    SE/W/0028/pdWS/002
    End of procedure: 16/10/2020
    Date of publication: 05/02/2021
  • Palexia and associated names (tapentadol hydrochloride)

    DE/W/083/pdWS/001

    End of procedure: 01/07/2014
    Date of publication: 09/10/2014

    DE/W/083/pdWS/002
    End of procedure: 15/12/2014
    Date of publication: 30/01/2015

    DE/W/123/pdWS/001
    End of procedure: 10/12/2019
    Date of publication: 09/03/2020

    DE/W/124/pdWS/001
    End of procedure: 19/11/2019
    Date of publication: 09/03/2020

    DE/W/125/pdWS/001
    End of procedure: 16/03/2020
    Date of publication: 11/05/2020
  • Pentavac/Pentaxim (diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugated vaccine (adsorbed))

    SE/W/0015/pdWS/001

    End of procedure: 19/12/2013
    Date of publication: 04/03/2014

    SE/W/0015/pdWS/002
    End of procedure: 17/04/2015
    Date of publication: 06/07/2015

    SE/W/0015/pdWS/003
    End of procedure: 19/12/2018
    Date of publication: 11/04/2019
  • Pneumovax and associated names (pneumococcal polysaccharide vaccine)

    UK/W/0078/pdWS/001
    End of procedure: 08/11/2014
    Date of publication: 30/01/2015

    DE/W/0080/pdWS/003
    End of procedure: 18/08/2022
    Date of publication: 25/10/2022
  • Priorix Tetra (measles, mumps and rubella vaccine)
     
    DE/W/0050/pdWS/001
    End of procedure: 12/10/2012
    Date of publication: 22/11/2012
     
    DE/W/0050/pdWS/002
    End of procedure: 25/04/2013
    Date of publication: 12/06/2013
     
    DE/W/0050/pdWS/003
    End of procedure: 25/04/2013
    Date of publication: 12/06/2013

  • Riamet (artemether / lumefantrine)

    UK/W/0096/pdWS/001
    End of procedure: 06/02/2017
    Date of publication: 03/04/2017

    SE/W/0032/pdWS/001
    End of procedure: 21/07/2021
    Date of publication: 03/05/2023

    SE/W/0032/pdWS/002
    End of procedure: 06/02/2024
    Date of publication: 02/05/2024
  • Seretide Diskus and associated names (fluticasone propionate / salmeterol xinafoate)
      

    SE/W/005/pdWS/001
    End of procedure: 12/01/2009
    Date of publication: 05/01/2011
     
    SE/W/005/pdWS/002
    End of procedure: 18/03/2013
    Date of publication: 20/06/2013 
     
    SE/W/005/pdWS/003

    End of procedure: 13/01/2015
    Date of publication: 01/04/2015

    SE/W/005/pdWS/004
    End of procedure: 12/04/2016
    Date of publication: 20/06/2016
  • Seroquel (quetapine)

    NL/W/004/pdWS/001

    End of procedure: 07/12/2009
    Date of publication: 26/09/2013
     
    NL/W/004/pdWS/002
    End of procedure: 17/12/2012
    Date of publication: 26/09/2013
  • Silkis ointment (calcitriol)

    NL/W/0049/pdWS/001
    End of procedure: 8/08/2018
    Date of publication: 31/07/2019

    NL/W/0049/pdWS/002
    End of procedure: 13/05/2020
    Date of publication: 08/07/2020
  • Singulair and associated names (montelukast)

    PL/W/0002/pdWS/001
    End of procedure: 20/12/2010
    Date of publication: 02/03/2011

    PL/W/0002/pdWS/002
    End of procedure: 17/04/2011
    Date of publication: 06/06/2011

    PL/W/0015/pdWS/001
    End of procedure: 29/05/2013
    Date of publication: 31/07/2013

    FI/W/007/pdWS/001
    End of procedure: 10/05/2015
    Date of publication: 06/07/2015
  • Tetravac / Tetraxim (diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis vaccine (inactivated) adsorbed)

    IE/W/0005/pdWS/001

    End of procedure: 01/11/2010
    Date of publication: 24/03/2011

    IE/W/0005/pdWS/002
    End of procedure: 29/03/2012
    Date of publication: 03/07/2012

    IE/W/0005/pdWS/003
    End of procedure: 09/01/2015
    Date of publication: 30/01/2015

    SE/W/0022/pdWS/001
    End of procedure: 19/12/2018
    Date of publication: 11/04/2019
  • Tobi / Tobi Podhaler (tobramycin)

    UK/W/0089/pdWS/001

    End of procedure: 22/06/2016
    Date of publication: 03/10/2016

    UK/W/0089/pdWS/002
    End of procedure: 20/12/2016
    Date of publication: 09/03/2017

    UK/W/0089/pdWS/003
    End of procedure: 18/12/2017
    Date of publication: 02/03/2018
  • Trileptal (oxcarbazepine)

    DK/W/0028/pdWS/001
    End of procedure: 08/06/2016
    Date of publication: 27/07/2016

    DK/W/0028/pdWS/002
    End of procedure: 21/06/2018
    Date of publication: 28/11/2018

    DK/W/0028/pdWS/003
    End of procedure: 1/12/2021
    Date of publication: 22/11/2023        
  • Varivax (varicella virus vaccine live)

    IT/W/0013/pdWS/02
    End of procedure: 19/03/2020
    Date of publication: 09/03/2021

    IT/W/0013/pdWS/04
    End of procedure: 01/07/2020
    Date of publication: 04/10/2021
  • Vaxigrip Tetra (quadrivalent influenza virus vaccine (inactivated, split))

    DE/W/0074/pdWS/003
    End of procedure: 10/07/2020
    Date of publication: 29/09/2020

    DE/W/0074/pdWS/004
    End of procedure: 04/07/2024
    Date of publication: 25/09/2024

  • Wilate and associated names (human von Willebrand factor / human coagulation factor VIII)

    DE/W/0078/pdWS/001
    End of procedure: 24/07/2020
    Date of publication: 29/09/2020

    DE/W/0078/pdWS/002
    End of procedure: 01/12/2023
    Date of publication: 31/01/2024
  • Zithromax (azithromycin (dehydrate))

    PT/W/0007/pdWS/001
    End of procedure: 04/01/2019
    Date of publication: 13/02/2019

    PT/W/0007/pdWS/002
    End of procedure: 13/04/2017
    Date of publication: 16/11/2022